Brilinta keeps platelets in the blood from clotting in order to prevent unwanted blood clots that may occur in heart or blood vessel complications. Brilinta is administered to lower the risks of getting a serious heart problem or stroke after a patient has experienced severe chest pain or heart attack. Brilinta works by lowering a patient's chance of having another heart attack or dying because of a heart attack.
Brilinta is a medicine used in the treatment of stroke, heart attack or angina. Brilinta is an inhibitor of platelet aggregation, platelet aggregation being the process that leads to clot formation. The active ingredient of Brilinta, ticagrelor, works by blocking ADP receptors (specifically, the P2Y12 subtype) on platelets, meaning that platelets are less likely to stick together.
Brilinta is therefore also used as a prophylactic medicine, in order that patients do not suffer from a stroke or heart attack in the future. Common side effects with Brilinta include headache, cough, mild dizziness, nausea, and diarrhea. Some patients experience nosebleeds, easy bruising, and stomach bleeding.